{"title":"2022 年澳大利亚维多利亚州诺如病毒发病率的变化:COVID 之后我们恢复正常了吗?","authors":"Leesa D Bruggink, Bruce Thorley","doi":"10.33321/cdi.2024.48.29","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>There were 108 norovirus-positive outbreaks in 2022, with 45 (41.7%) occurring during the first quarter (Q1), January-March. Aged care facilities accounted for 44.4% of norovirus-positive outbreaks; 43.5% were in childcare settings. Overall, the GII.P31/GII.4 genotype was the most common, involved in 39.4% of outbreaks; however, there were shifts in the most common genotype across the year. In Q1, the GII.P31/GII.4 genotype accounted for 73.3% of typed outbreaks, but by Q3 (July-September) the GII.P7/GII.6 was the most prominent genotype at 45.0%. In Q4 (October-December), the dominant genotype had changed again to GII.P16/GII.4 (52.6%). While the incidence of norovirus outbreaks in 2022 was average regarding overall prevalence and genotype diversity, there are still ongoing effects from the coronavirus disease 2019 (COVID-19) pandemic in relation to seasonality, outbreak demographics and specimen referral.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changes in norovirus incidence in Victoria, Australia, 2022: are we back to normal yet after COVID?\",\"authors\":\"Leesa D Bruggink, Bruce Thorley\",\"doi\":\"10.33321/cdi.2024.48.29\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Abstract: </strong>There were 108 norovirus-positive outbreaks in 2022, with 45 (41.7%) occurring during the first quarter (Q1), January-March. Aged care facilities accounted for 44.4% of norovirus-positive outbreaks; 43.5% were in childcare settings. Overall, the GII.P31/GII.4 genotype was the most common, involved in 39.4% of outbreaks; however, there were shifts in the most common genotype across the year. In Q1, the GII.P31/GII.4 genotype accounted for 73.3% of typed outbreaks, but by Q3 (July-September) the GII.P7/GII.6 was the most prominent genotype at 45.0%. In Q4 (October-December), the dominant genotype had changed again to GII.P16/GII.4 (52.6%). While the incidence of norovirus outbreaks in 2022 was average regarding overall prevalence and genotype diversity, there are still ongoing effects from the coronavirus disease 2019 (COVID-19) pandemic in relation to seasonality, outbreak demographics and specimen referral.</p>\",\"PeriodicalId\":36867,\"journal\":{\"name\":\"Communicable diseases intelligence (2018)\",\"volume\":\"48 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Communicable diseases intelligence (2018)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33321/cdi.2024.48.29\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communicable diseases intelligence (2018)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33321/cdi.2024.48.29","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Changes in norovirus incidence in Victoria, Australia, 2022: are we back to normal yet after COVID?
Abstract: There were 108 norovirus-positive outbreaks in 2022, with 45 (41.7%) occurring during the first quarter (Q1), January-March. Aged care facilities accounted for 44.4% of norovirus-positive outbreaks; 43.5% were in childcare settings. Overall, the GII.P31/GII.4 genotype was the most common, involved in 39.4% of outbreaks; however, there were shifts in the most common genotype across the year. In Q1, the GII.P31/GII.4 genotype accounted for 73.3% of typed outbreaks, but by Q3 (July-September) the GII.P7/GII.6 was the most prominent genotype at 45.0%. In Q4 (October-December), the dominant genotype had changed again to GII.P16/GII.4 (52.6%). While the incidence of norovirus outbreaks in 2022 was average regarding overall prevalence and genotype diversity, there are still ongoing effects from the coronavirus disease 2019 (COVID-19) pandemic in relation to seasonality, outbreak demographics and specimen referral.